31P-MR spectroscopic imaging in hypertensive heart disease

[1]  R. Wiseman,et al.  31P-NMR observation of free ADP during fatiguing, repetitive contractions of murine skeletal muscle lacking AK1. , 2005, American journal of physiology. Cell physiology.

[2]  R. Walsh,et al.  In vivo phosphorus-31 NMR spectroscopy of abnormal myocardial high-energy phosphate metabolism during cardiac stress in hypertensive-hypertrophied non-human primates , 1990, The International Journal of Cardiac Imaging.

[3]  W. Kaiser,et al.  Noninvasive measurements of cardiac high-energy phosphate metabolites in dilated cardiomyopathy by using 31P spectroscopic chemical shift imaging , 2005, European Radiology.

[4]  J. Sandstede,et al.  Detection of myocardial infarctions by acquisition‐weighted 31P‐MR spectroscopy in humans , 2004, Journal of magnetic resonance imaging : JMRI.

[5]  Robert G Weiss,et al.  Is the failing heart energy starved? On using chemical energy to support cardiac function. , 2004, Circulation research.

[6]  M. Beer.  Cardiac spectroscopy: techniques, indications and clinical results , 2004, European Radiology.

[7]  G. Hatch.  Cell biology of cardiac mitochondrial phospholipids. , 2004, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[8]  Andre Terzic,et al.  Phosphotransfer dynamics in skeletal muscle from creatine kinase gene-deleted mice , 2004, Molecular and Cellular Biochemistry.

[9]  Carmen Drahl,et al.  Mapping hypoxia-induced bioenergetic rearrangements and metabolic signaling by 18O-assisted 31P NMR and 1H NMR spectroscopy , 2004, Molecular and Cellular Biochemistry.

[10]  M. Hennersdorf,et al.  [Regression of left ventricular hypertrophy in hypertensive heart disease]. , 2003, Herz.

[11]  M. Hennersdorf,et al.  Hypertrophieregression als Therapieprinzip des Hochdruckherzens , 2003, Herz.

[12]  N. Kervarec,et al.  Distribution and Potential Role of Cytosolic Water‐Soluble Phosphodiesters in Fish , 2003, Physiological and Biochemical Zoology.

[13]  C. Kremser,et al.  Impact of aging on cardiac high-energy phosphate metabolism determined by phosphorus-31 2-dimensional chemical shift imaging (31P 2D CSI). , 2003, Magnetic resonance imaging.

[14]  Stefan Neubauer,et al.  Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy. , 2002, Journal of the American College of Cardiology.

[15]  S. Neubauer,et al.  Mitochondrial creatine kinase is critically necessary for normal myocardial high-energy phosphate metabolism. , 2002, American journal of physiology. Heart and circulatory physiology.

[16]  K. Weber.  Cardioreparation in Hypertensive Heart Disease , 2001, Hypertension.

[17]  K. Weber,et al.  Targeting pathological remodeling: concepts of cardioprotection and reparation. , 2000, Circulation.

[18]  O. Lutz,et al.  Differences in cardiac energetics between patients with familial and nonfamilial hypertrophic cardiomyopathy. , 2000, Circulation.

[19]  B. Strauer,et al.  Age-related decline of PCr/ATP-ratio in progressively hypertrophied hearts of spontaneously hypertensive rats , 2000, Heart and Vessels.

[20]  B. Stoel,et al.  Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism. , 1999, Circulation.

[21]  M. Thelen,et al.  Dynamic phosphorus-31 magnetic resonance spectroscopy of the quadriceps muscle: effects of age and sex on spectroscopic results. , 1999, Investigative radiology.

[22]  A Haase,et al.  Localized spectroscopy from anatomically matched compartments: improved sensitivity and localization for cardiac 31P MRS in humans. , 1998, Journal of magnetic resonance.

[23]  O. Lutz,et al.  31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. , 1998, Circulation.

[24]  B. Rajagopalan,et al.  Mitral regurgitation: impaired systolic function, eccentric hypertrophy, and increased severity are linked to lower phosphocreatine/ATP ratios in humans. , 1998, Circulation.

[25]  T. Inubushi,et al.  Influence of aging or left ventricular hypertrophy on the human heart: Contents of phosphorus metabolites measured by 31P MRS , 1998, Magnetic resonance in medicine.

[26]  J. Wasser,et al.  In vitro tolerance to anoxia and ischemia in isolated hearts from hypoxia sensitive and hypoxia tolerant turtles. , 1997, Comparative biochemistry and physiology. Part A, Physiology.

[27]  S. Neubauer,et al.  Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. , 1997, Circulation.

[28]  S. Neubauer,et al.  Cardiac high-energy phosphate metabolism in patients with aortic valve disease assessed by 31P-magnetic resonance spectroscopy. , 1997, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[29]  G. Hatch,et al.  Phospholipid metabolism in the mammalian heart. , 1997, Progress in lipid research.

[30]  V. Pelouch,et al.  Phospholipid composition in the rat heart exposed to pressure overload from birth. , 1996, Physiological research.

[31]  A. From,et al.  Effect of left ventricular hypertrophy secondary to chronic pressure overload on transmural myocardial 2-deoxyglucose uptake. A 31P NMR spectroscopic study. , 1995, Circulation.

[32]  P A Bottomley,et al.  MR spectroscopy of the human heart: the status and the challenges. , 1994, Radiology.

[33]  C. Burt,et al.  Glycerol phosphorylcholine (GPC) and serine ethanolamine phosphodiester (SEP): evolutionary mirrored metabolites and their potential metabolic roles. , 1994, Comparative biochemistry and physiology. Biochemistry and molecular biology.

[34]  K Ugurbil,et al.  Bioenergetic abnormalities associated with severe left ventricular hypertrophy. , 1993, The Journal of clinical investigation.

[35]  S. Neubauer,et al.  31P-Kardio-MR-Spektroskopie bei Myokardinsuffizienz , 1993, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[36]  K. Takeda,et al.  31P MR spectroscopy in hypertrophic cardiomyopathy: comparison with Tl-201 myocardial perfusion imaging. , 1993, American heart journal.

[37]  S. Neubauer,et al.  31P Magnetic Resonance Spectroscopy in Dilated Cardiomyopathy and Coronary Artery Disease: Altered Cardiac High‐Energy Phosphate Metabolism in Heart Failure , 1992, Circulation.

[38]  S. Neubauer,et al.  [The direct measurement of the spin-grid-relaxation times of phosphorus metabolites in the human myocardium]. , 1992, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[39]  E. E. van der Wall,et al.  Cardiac metabolism in patients with dilated and hypertrophic cardio‐myopathy: Assessment with proton‐decoupled P‐31 MR spectroscopy , 1992, Journal of Magnetic Resonance Imaging.

[40]  P. Douglas,et al.  Creatine kinase kinetics studied by phosphorus-31 nuclear magnetic resonance in a canine model of chronic hypertension-induced cardiac hypertrophy , 1992 .

[41]  P. Douglas,et al.  Creatinine kinase kinetics studied by phosphorus-31 nuclear magnetic resonance in a canine model of chronic hypertension-induced cardiac hypertrophy. , 1992, Journal of the American College of Cardiology.

[42]  G. Mckinnon,et al.  [In vivo 31P-cardiac magnetic resonance spectroscopy: methods and the first clinical results]. , 1991, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[43]  C. Higgins,et al.  Normal and diffusely abnormal myocardium in humans: functional and metabolic characterization with P-31 MR spectroscopy and cine MR imaging. , 1991, Radiology.

[44]  S. Schaefer.  Clinical nuclear magnetic resonance spectroscopy: insight into metabolism. , 1990, The American journal of cardiology.

[45]  R. Shemin,et al.  The creatine kinase system in normal and diseased human myocardium. , 1985, The New England journal of medicine.

[46]  A. Wechsler,et al.  Derangements in myocardial purine and pyrimidine nucleotide metabolism in patients with coronary artery disease and left ventricular hypertrophy. , 1982, Proceedings of the National Academy of Sciences of the United States of America.